EUVIMEDEUVIMED entdecken
Crossref

Effect of imatinib on lipopolysaccharide‑induced acute lung injury and endothelial dysfunction through the P38 MAPK and NF-κB signaling pathways in vivo and in vitro

Yaru Liu, Duanyang Li, Tianyi Zhang, Keruo Wang, Xue Liang, Xiaolong Zong, Hong Yang, Zhenyu Li

Respiratory Physiology & Neurobiology · 2025

DOI: 10.1016/j.resp.2024.104388 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respiratory Physiology & Neurobiology, 2025. Verfasst von Yaru Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine,The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Imatinib Mesylate, NF-kappa B, p38 Mitogen-Activated Protein Kinases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The primary purpose of this study was to demonstrate the preventive effects of imatinib (IMA) on lipopolysaccharide (LPS)-induced inflammation in a mouse model of acute lung injury (ALI) and human umbilical vascular endothelial cells. METHODS: LPS stimulation for 24 h induced ALI and cell inflammation. The pathological results of the lungs were evaluated using the wet/dry weight ratio, pulmonary vascular permeability measurements, and myeloperoxidase immunohistochemistry. The expression of pro-inflammatory mediators was analyzed using RT-PCR and enzyme-linked immunosorbent assay. Protein levels were analyzed using western blotting. The structure of cell junctions was detected using immunofluorescence. RESULTS: IMA improved LPS-induced pulmonary pathological damage and reduced the lung wet/dry weight ratio and myeloperoxidase expression in the lung tissue. IMA decreased bronchoalveolar lavage fluid inflammatory cell count and the release of tumor necrosis factor-α (TNF-α), interleukin (IL)-6, and monocyte chemotactic protein 1 (MCP-1) in the blood. Pretreatment of human umbilical vascular endothelial cells with IMA significantly attenuated LPS-induced actin stress fiber formation and vascular endothelial-cadherin disruption. In addition, IMA downregulated the mRNA abundances of vascular cell adhesion molecule 1, intercellular adhesion molecule 1, IL-1β, IL-6, and tumor necrosis factor-α(TNF-α) expression. The phosphorylation of p65, nuclear factor-kappa B inhibitor alpha (IκBα), p38, extracellular signal-regulated kinase, and Jun N-terminal kinase induced by LPS were attenuated after IMA treatment in vivo and in vitro. CONCLUSIONS: IMA modulates the nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways and the production of pro-inflammatory cytokines to prevent cellular damage due to LPS infection. These results indicate that IMA may be a potential modulator of LPS-induced ALI.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Lung InjuryImatinib MesylateNF-kappa Bp38 Mitogen-Activated Protein KinasesProtein Kinase InhibitorsLipopolysaccharidesAnimalsHumansHuman Umbilical Vein Endothelial CellsSignal TransductionDisease Models, AnimalMaleMiceLungMice, Inbred C57BLCells, Cultured

Stichwörter der Autor:innen

Acute lung injuryEndothelial dysfunctionImatinibMAPKNF-κB

Substanzen

LipopolysaccharidesImatinib MesylateNF-kappa Bp38 Mitogen-Activated Protein KinasesProtein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Emergency Medicine,The Second Hospital of Tianjin Medical University, Tianjin 300211, China.
  • Department of Urology, The Second Hospital of Tianjin Medical University, Tianjin 300211 China.
  • Tianjin Institute of Cardiology, Tianjin 300211,China.
  • Department of Clinical Laboratory, The Second Hospital of Tianjin Medical University, Tianjin 300211,China.
  • School of Biomedical Engineering and The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Tianjin Medical University, Tianjin 300070, China. Electronic address: hongyang@tmu.ed…
  • Department of Emergency Medicine,The Second Hospital of Tianjin Medical University, Tianjin 300211, China. Electronic address: doctorlzy2022@163.com.

Zitieren

APA

Liu, Y., Li, D., Zhang, T., Wang, K., Liang, X., Zong, X., Yang, H., & Li, Z. (2025). Effect of imatinib on lipopolysaccharide‑induced acute lung injury and endothelial dysfunction through the P38 MAPK and NF-κB signaling pathways in vivo and in vitro. Respiratory Physiology & Neurobiology. https://doi.org/10.1016/j.resp.2024.104388

Vancouver

Liu Y, Li D, Zhang T, Wang K, Liang X, Zong X, et al. Effect of imatinib on lipopolysaccharide‑induced acute lung injury and endothelial dysfunction through the P38 MAPK and NF-κB signaling pathways in vivo and in vitro. Respiratory Physiology & Neurobiology. 2025. doi:10.1016/j.resp.2024.104388

BibTeX
@article{Liu2025,
  author = {Liu, Yaru and Li, Duanyang and Zhang, Tianyi and Wang, Keruo and Liang, Xue and Zong, Xiaolong and Yang, Hong and Li, Zhenyu},
  title = {Effect of imatinib on lipopolysaccharide‑induced acute lung injury and endothelial dysfunction through the P38 MAPK and NF-κB signaling pathways in vivo and in vitro},
  journal = {Respiratory Physiology & Neurobiology},
  year = {2025},
  doi = {10.1016/j.resp.2024.104388}
}
Kostenlos starten →